Mammakarzinom – komplementäre Praxis

Zusammenfassung

Komplementäre onkologische Therapieverfahren ergänzen und bereichern die konventionellen Therapien der evidenzbasierten Schulmedizin (OP, Strahlen-, Chemo- und Antihormontherapie u. a.). Dazu gehören Methoden, die in jedem Stadium einer Krebserkrankung sinnvoll in ein koordiniertes Gesamtkonzept durch die behandelnden Chirurgen, Onkologen, Strahlentherapeuten und einem komplementären Arzt eingebettet sein sollten sowie vom Patienten selbst angewendet werden können und die von einer erweiterten Diagnostik über allgemeine Basismaßnahmen über Bewegung und Ernährung bis hin zur Anwendung von orthomolekularen Substanzen, Phytotherapie und sekundärer Pflanzenstoffe sowie weiterer komplementärer Verfahren reichen.

Abstract

Complementary oncological therapies supplement and enrich the conventional therapies of evidence-based orthodox medicine (surgery, radiation therapy, chemotherapy and antihormone therapy etc.). This includes methods, which should be appropriately embedded in a coordinated overall concept by the attending surgeon, oncologist, radiotherapist, and a complementary physician in every stage of a cancer disease, which can be used by the patients themselves, and which range from advanced diagnostics, a general basic measure, exercise and nutrition to the use of orthomolecular substances, phytotherapy and secondary plant substances as well as other complementary procedures.

Schlüsselwörter

Mammakarzinom - Komplementärmedizin - Ernährung - orthomolekulare Medizin - Immunologie

Key words

Mammary carcinoma - complementary medicine - nutrition - orthomolecular medicine - immunology

• Literatur

• 1 Abbas S, Linseisen J, Slanger T. et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case–control study. Carcinogenesis 2007; 29 (01) 93-99
• 2 Adams TD, Hunt SC. Cancer and obesity: effect of bariatric surgery. World journal of surgery 2009; 33: 2028-2033
• 3 Albrecht A. „Gefährliche Heiler“ – Wie Alternativ-Mediziner die Not ihrer Patienten ausnutzen. Stern 2014; 28
• 4 Bedogni A, Saia G, Bettini G. et al. Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?. The oncologist 2012; 17: 1114-1119
• 5 Berg PA, Stein GM. Beeinflusst die Misteltherapie die Abwehr epithelialer Tumoren? Eine kritische immunologische Analyse. DMW-Deutsche Medizinische Wochenschrift 2001; 126: 339-345
• 6 Bergman P, Sperneder S, Höijer J. et al. Low vitamin D levels are associated with higher opioid dose in palliative cancer patients–results from an observational study in Sweden. PLoS One 2015; 10 e0128223
• 7 Beuth J. Krebsprävention durch Lebensführung – was ist gesichert?. Best practice onkologie 2013; 8: 6-13
• 8 Beuth J. Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction?. Integr Cancer Ther 2008; 7: 311-316
• 9 Beuth J, Ost B, Pakdaman A. et al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients–results of an epidemiological multicentre retrolective cohort study. Cancer chemotherapy and pharmacology 2001; 47: S45-S54
• 10 Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality amoung US adults. Arch Intern Med 2008; 168: 404-10
• 11 Bøhn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Molecular nutrition & food research 2014; 58: 915-930
• 12 Bojko P, Schimmel G, Bosse D. et al. Metronomic Oral Cyclophosphamide in Patients with Advanced Solid Tumors. Onkologie 2012; 35: 35-38
• 13 Bowers LW. NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin–Aromatase Interactions. Cancer Res 2014; 74: 4446-4457
• 14 Burd R, Dziedzic TS, Xu Y. et al. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia. Journal of cellular physiology 1998; 177: 137-147
• 15 Calderwood SK, Murshid A, Gong J. Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity. Front Immunol 2012; 3: 75
• 16 Cefak KG. Cefasel: Ergebnisse einer multizentrischen Anwendungsbeobachtung. Beilage zu “Der Bayrische Internist”. 2010
• 17 Chen YC, Sosnoski DM, Gandhi UH. et al. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. Carcinogenesis 2009; 30: 1941-1948
• 18 Chen Q, Espey MG, Sun AY. et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci 2008; 105: 11105-11109
• 19 Chi F. et al. Post-diagnosis soy food intake and breast cancer survival: a metaanalysis of cohort studies. Asian Pac J Cancer Prev 2013; 14: 2407-12
• 20 Churilla TM, Brereton HD, Klem M. Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer 2012; 64: 521-525
• 21 Colomer R, Moreno-Nogueira JM, García-Luna PP. et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007; 97: 823-831
• 22 Cruciani RA, Dvorkin E, Homel P. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann NY Acad Sci 2004; 1033: 168-176
• 23 Dziaman T, Huzarski T, Gackowski D. et al. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiology and Prevention Biomarkers 2009; 18: 2923-2928
• 24 Emond JA. Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor. Cancer Epidemiology and Prevention Biomarkers 2014; 23: 1273-1279
• 25 Esposito K, Chiodini P, Colao A. et al. Metabolic Syndrome and Risk of Cancer – A systematic review and meta-analysis. Diabetes Care 2012; 35: 2402-2411
• 26 Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nature reviews. Immunology 2015; 15: 335
• 27 Fink M. Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia. J Clin Oncol 2011; 29: e81-e82
• 28 Franca CAS, Nogueira CR, Ramalho A. et al. Serum levels of selenium in patients with breast cancer before and after treatment of external beam radiotherapy. Annals of oncology 2010; 22: 1109-1112
• 29 Friesen C, Addeo R, Caraglia M. et al. D, L-Methadon erhöht den zytotoxischen Effekt konventioneller Krebstherapien. Dtsch Z Onkol 2017; 49: 61-67
• 30 Fritz H. et al. Intravenous Vitamin C and Cancer. A Systematic Review. Integr Cancer Ther 2014; 13: 280-300
• 31 Garland CF, Gorham ED, Mohr SB. et al. Vitamin D and prevention of breast cancer: pooled analysis. The Journal of steroid biochemistry and molecular biology 2007; 103 (03) 708-711
• 32 Gebauer F, Micheel B, Stauder G. et al. Proteolytic Enzymes Modulate the Adhesion Molecule CD44 on Malignant Cells in Vitro. Int. J. Immunotherapy 1997; 13: 111-119
• 33 Gonzalez CA, Riboli E. Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. European journal of cancer 2010; 46: 2555-2562
• 34 Goodwin PJ, Ennis M, Pritchard KI. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009; 27: 3757-3763
• 35 Gröber U, Mücke R, Adamietz IA. et al. Komplementärer Einsatz von Antioxidanzien und Mikronährstoffen in der Onkologie. Update 2013. Onkologe 2013; 19: 136-143
• 36 Gröber U. Neuroenhancement mit α-Liponsäure. ZKM 2012; 1: 45-49
• 37 Gröber U, Hübner J, Holzhauer P. Vitamin C in der komplementären Onkologie. Onkologe 2010; 16: 303-313
• 38 Harris RE, Beebe-Donk J, Doss H. et al. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade. Oncology Reports 2005; 13: 559-583
• 39 Hong SA, Kim K, Nam SJ. et al. A case–control study on the dietary intake of mushrooms and breast cancer risk among Korean women. International journal of cancer 2008; 122: 919-923
• 40 Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clinical Oncology 2007; 19: 418-426
• 41 Jin HW, Flatters SJ, Xiao WH. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol 2008; 210: 229-237
• 42 Jones EL, Oleson JR, Prosnitz LR. et al. Randomized trial of hyperthermia and radiation for superficial tumors. Journal of Clinical Oncology 2005; 23: 3079-3085
• 43 Kasseroller RG, Schrauzer GN. Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review. American journal of therapeutics 2000; 7: 27-279
• 44 Kemper G. Brustkrebs und Umweltbelastungen: Erkennen, verstehen, vermeiden. Dtsch Z Onkol 2016; 48: 29-34
• 45 Khan QJ, Reddy PS, Kimler BF. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 2010; 119: 111-118
• 46 Kim YS. et al. Cancer steam cells: potential target for bioactive food components. J Nutr Biochem 2012; 23: 691-698
• 47 Kindler M. Factor AF2 als Begleitmaßnahme zur Chemotherapie – myeloprotektive und antiemetische Wirkungen. Z Onkol 1997; 29: 7-10
• 48 Klingmüller D, Alléra A. Endokrin aktive Substanzen in der Umwelt (Endocrine Disruptors): Gefahr für den Menschen?. DMW-Deutsche Medizinische Wochenschrift 2011; 136: 967-972
• 49 Konklin KA. Coenzyme Q10 for Prevention of Anthracycline-Induced Cardiotoxicity. Integr Cancer Ther 2005; 4: 110-130
• 50 Kowalska E, Narod SA, Huzarski T. et al. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiology and Prevention Biomarkers 2005; 14: 1302-1306
• 51 Lappe JM, Travers-Gustafson D, Davies KM. et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591
• 52 Lee IM, Wolin KY, Freeman SE. et al. Physical activity and survival after cancer diagnosis in men. Journal of Physical Activity and Health 2014; 11: 85-90
• 53 Levitsky DO, Dembitsky VM. Anti-breast cancer agents derived from plants. Natural products and bioprospecting 2015; 5: 1-16
• 54 Li S, Li Q, Li Y. et al. Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PloS one 2015; 10: e0119479
• 55 Libby G, Donnelly LA, Donnan PT. et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes care 2009; 32: 1620-1625
• 56 Lin YS, Lin LC, Lin SW. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow- up of a double-blind randomized study with subgroup analysis. Laryngoscope 2009; 119: 1348-1352
• 57 Lipinski B. 2005; Rationale for the treatment of cancer with sodium selenite. Medical hypotheses 64 (04) 806-810
• 58 Lippmann SM, Davies PJ. Retinoids, neoplasia and differentiation therapy. Cancer Chemother Biol Response Modif 1997; 17: 349-362
• 59 Liu X, Lv K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis. The Breast 2013; 22: 309-313
• 60 Lopez-Saez JB, Senra-Varela A, Pousa-Estevez L. Selenium in breast cancer. Oncology 2003; 64: 227-231
• 61 Magee PJ, Rowland I. Soy products in the management of breast cancer. Current Opinion in Clinical Nutrition & Metabolic Care 2012; 15: 586-591
• 62 Mahmoud SM, Paish EC, Powe DG. et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Journal of clinical oncology 2011; 29: 1949-1955
• 63 Messina M. et al. It‘s time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Breast Cancer, Oncology Journal. 2013
• 64 Mills E, Wu P, Seely D. et al. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. Journal of Pineal Research 2005; 39: 360-366
• 65 Mohr SB, Gorham ED, Kim J. et al. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer research 2014; 34: 1163-1166
• 66 Moore SC, Lee IM, Weiderpass E. et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA internal medicine 2016; 176: 816-825
• 67 Mücke R, Schomburg L, Büntzel J. Komplementärer Seleneinsatz in der Onkologie. Onkologe 2010; 16: 181-186
• 68 Münstedt K, Männle H. Grüner Tee zur primären und tertiären Prophylaxe des Mammakarzinoms. Dtsch Z Onkol 2015; 47: 10-12
• 69 Multhoff G, Radons J. Radiation, Inflammation, and Immune Responses in Cancer. Front Oncol 2012; 2: 58
• 70 Nakachi K, Suemasu K, Suga K. et al. Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients. Jpn J Cancer Res 1998; 89: 254-261
• 71 Nechuta SJ. et al. Soy food intake after diagnosis of brest cancer and survival: an indepth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr 2012; 96: 123-132
• 72 Nechuta S, Lu W, Chen Z. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2011; 20: 262-271
• 73 Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients. International Journal of Hyperthermia 2017; 33: 227-236
• 74 Oh JK, Sandin S, Ström P. et al. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. International journal of cancer 2015; 137: 1979-1989
• 75 Pirouzpanah MB, Sabzichi M, Pirouzpanah S. et al. Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways. Asian Pac J Cancer Prev 2015; 16: 2087-92
• 76 Potter GA, Burke MD. Salvestrols – Natural Products with Tumor Selective Activity. J Orthomol Med 2006; 21: 34-36
• 77 Pouchieu C, Galan P, Ducros V. et al. Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study. Nutrition and cancer 2014; 66: 980-988
• 78 Prieto-Alhambra D, Javaid MK, Servitja S. Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospectiv cohort study. Breast Cancer Res Treat 2011; 125: 869-878
• 79 Roffe L, Schmidt K, Ernst E. Efficacy of Coenzyme Q10 for Improved Tolerability of Cancer Treatments: A Systematic Review. J Clin Oncol 2004; 22: 4418-4424
• 80 Santini D, Galluzzo S, Vincenzi B. Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients. Ann Oncol 2010; 21: 185-186
• 81 Sartippour MR, Shao ZM, Heber D. et al. Green Tea Inhibits Vascular Endothelial Growth Factor (VEGF) Induction in Human Breast Cancer Cells. J Nutr 2002; 132: 2307-2311
• 82 Schilling S. Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility. Dtsch Arztebl Int 2012; 109: 33-38
• 83 Schwaab J, Horisberger K, Erben P. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011; 11: 363
• 84 Semiglasov VF, Stepula VV, Dudov A. et al. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer research 2004; 24: 1293-1302
• 85 Singh Sidhu J, Singla R, Jaitak V. Indole derivatives as anticancer agents for breast cancer therapy: a review. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2016; 16: 160-173
• 86 Sinha D, Biswas J, Sung B. et al. Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer. Current Drug Targets 2012; 13: 1799-1819
• 87 Slivova V, Zaloga G, DeMichele SJ. et al. Green Tea Polyphenols Modulate Secretion of Urokinase Plasminogen Activator (uPA) and Inhibit Invasive Behavior of Breast Cancer Cells. Nutrition and Cancer 2005; 52: 66-73
• 88 Solomayer EF, Feuerer M, Bai L. et al. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clinical Cancer Research 2003; 9: 174-180
• 89 Stoll G. Thymuspeptide in der Onkologie. Z Onkol 1999; 31: 1-7
• 90 Thomson CA, Rock CL, Thompson PA. et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study. Breast cancer research and treatment 2011; 125: 519-527
• 91 Tröger W, Ždrale Z, Stanković N. Fünf-Jahres-Nachbeobachtung von Patientinnen mit Brustkrebs nach einer randomisierten Studie mit Viscum album (L.) Extrakt. Dtsch Z Onkol 2016; 48: 105-110
• 92 Vainio H, Rautalahti M. An international evaluation of the cancer preventive potential of vitamin A. Cancer Epidemiology Biomarkers and Prevention 1999; 8: 107-109
• 93 Verma C, Kaewkangsadan V, Eremin JM. et al. Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery. Journal of translational medicine 2015; 13: 180
• 94 Visovsky C, Collins M, Abbott L. et al. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 2007; 11: 901-913
• 95 Vollbracht C, Schneider B, Leendert V. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo 2011; 25: 983-990
• 96 Vormann J. Physiologie und Pathophysiologie von Magnesium. Schw Zeitschr Ernährungsmed 2010; 1: 8-13
• 97 Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene 2008; 27: 5932
• 98 Wallace JM. Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy. Integr Cancer Ther 2002; 1: 7-37
• 99 Walraven I, Riet E, Stehouwer CDA. et al. High proinsulin levels are independently associated with 20-year cancer mortality. The Hoorn study Presentation. Poster Nr. 234 bei 49. EASD-Kongress 2013 in Barcelona.
• 100 Weigelin B, Anderson MD. Activating serial killers: Hyperthermia as supporting strategy for cancer immunotherapy. Vortrag zum VII. Hyperthermie-Kongress, Berlin, September 2016, Zsf in: Aktuelle Gesundheitsnachrichten, Heft 23/2016 der Europäischen Akademie für Naturheilkunde und Umweltmedizin.
• 101 Wey S. L-Carnitin − Porträt einer Aminosäure. Zsf.Orthomol.Med 2015; 2: 19-22
• 102 Wu X, Tang J, Xie M. Serum and hair zinc levels in breast cancer: a meta-analysis. Scientific reports 2015; 5: 12249
• 103 Wust P, Hildebrandt B, Sreenivasa G. et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002; 3: 487-497
• 104 Zhang L, Conejo-Garcia JR, Katsaros D. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-213
• 105 Zhang XH, Ma J, Smith-Warner SA. et al. Vitamin B6 and colorectal cancer: Current evidence and future directions. World J Gastroenterol 2013; 19: 1005-1010
• 106 Zheng N, Liu L, Liu W. et al. ERβ up-regulation was involved in silibinin-induced growth inhibition of human breast cancer MCF-7 cells. Archives of biochemistry and biophysics 2016; 591: 141-149